GlassScriptPhysician profile
Ellen Michelle Toneff
NPI 1326603143
$60,418.23
in general payments reported to CMS, 2019-2025
36 companies · $29K in 2025
The $29K reported for 2025 was more than what 99% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,093 · 2022: $4,094 · 2023: $13K · 2024: $13K · 2025: $29K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $34K · Food and Beverage: $12K · Travel and Lodging: $5,033 · Consulting Fee: $2,516 · Honoraria: $565 · Education: $431.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $34,400.00 |
| Food and Beverage | $12,287.48 |
| Travel and Lodging | $5,032.51 |
| Consulting Fee | $2,515.50 |
| Honoraria | $565.00 |
| Education | $430.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $39,391.56 | 2021-2025 | |
| Galderma Laboratories, L.P. | $8,315.95 | 2021-2025 | Nemluvio, Aklief, Oracea |
| Regeneron Healthcare Solutions, INC. | $1,789.23 | 2021-2025 | Dupixent, Libtayo |
| Novartis Pharmaceuticals Corporation | $1,442.67 | 2021-2025 | |
| Janssen Biotech, INC. | $1,323.23 | 2021-2025 | Tremfya, Simponi, Simponi Aria |
| Arcutis Biotherapeutics, INC. | $1,166.16 | 2023-2025 | Zoryve |
| Sun Pharmaceutical Industries INC. | $1,092.15 | 2021-2025 | Absorica Ld, Winlevi, Ilumya |
| Lilly USA, LLC | $798.67 | 2021-2025 | Olumiant, Taltz, Ebglyss |
| Genzyme Corporation | $698.53 | 2021-2025 | |
| Amgen INC. | $673.29 | 2021-2025 | Otezla, Otezla |
| E.R. Squibb & Sons, L.L.C. | $452.93 | 2022-2025 | Sotyktu |
| Ucb, INC. | $359.63 | 2024-2025 | Bimzelx |
| Kerecis Limited | $285.57 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Incyte Corporation | $283.77 | 2022-2025 | Opzelura |
| Boehringer Ingelheim Pharmaceuticals, INC. | $276.50 | 2022-2025 | Spevigo |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $251.34 | 2022-2025 | Siliq, Targretin, Cabtreo |
| Pfizer INC. | $247.52 | 2021-2025 | |
| Leo Pharma INC. | $243.78 | 2021-2025 | Adbry |
| Mayne Pharma Commercial LLC | $214.95 | 2021-2025 | |
| Dermavant Sciences, INC. | $201.33 | 2023-2024 | Vtama |
| Journey Medical Corporation | $117.94 | 2022 | |
| Organon LLC | $101.57 | 2025 | Vtama |
| Janssen Scientific Affairs, LLC | $95.25 | 2022 | |
| Almirall LLC | $84.04 | 2021-2023 | Seysara |
| Kyowa Kirin, INC. | $78.28 | 2021-2023 | Poteligeo |
| Smith+Nephew, INC. | $76.21 | 2023-2025 | Collagenase Santyl, Grafix Pl |
| Epi Health, LLC | $76.10 | 2021-2022 | |
| Sebela Pharmaceuticals INC. | $58.98 | 2022-2023 | Pramosone, Naftin |
| Mallinckrodt Hospital Products INC. | $38.71 | 2025 | Acthar |
| Botanix Sb INC | $37.85 | 2025 | Sofdra |
| Genentech USA, INC. | $32.82 | 2021 | |
| Sanofi-Aventis U.S. LLC | $29.00 | 2021 | |
| Verrica Pharmaceuticals INC. | $23.95 | 2024 | Ycanth |
| Paratek Pharmaceuticals, INC. | $22.62 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $20.39 | 2022 | |
| Convatec INC. | $15.76 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ellen Toneff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.